148 related articles for article (PubMed ID: 26091900)
1. Identification and characterization of reactive metabolites in myristicin-mediated mechanism-based inhibition of CYP1A2.
Yang AH; He X; Chen JX; He LN; Jin CH; Wang LL; Zhang FL; An LJ
Chem Biol Interact; 2015 Jul; 237():133-40. PubMed ID: 26091900
[TBL] [Abstract][Full Text] [Related]
2. Roles of human liver cytochrome P450 3A4 and 1A2 enzymes in the oxidation of myristicin.
Yun CH; Lee HS; Lee HY; Yim SK; Kim KH; Kim E; Yea SS; Guengerich FP
Toxicol Lett; 2003 Feb; 137(3):143-50. PubMed ID: 12523956
[TBL] [Abstract][Full Text] [Related]
3. Identification and analysis of the reactive metabolites related to the hepatotoxicity of safrole.
Yang AH; Zhang L; Zhi DX; Liu WL; Gao X; He X
Xenobiotica; 2018 Nov; 48(11):1164-1172. PubMed ID: 29082813
[TBL] [Abstract][Full Text] [Related]
4. Myristicin from nutmeg induces apoptosis via the mitochondrial pathway and down regulates genes of the DNA damage response pathways in human leukaemia K562 cells.
Martins C; Doran C; Silva IC; Miranda C; Rueff J; Rodrigues AS
Chem Biol Interact; 2014 Jul; 218():1-9. PubMed ID: 24792648
[TBL] [Abstract][Full Text] [Related]
5. In vitro metabolism of 4, 5-dimethoxycanthin-6-one by human liver microsomes and its inhibition on human CYP1A2.
Miao X; You J; Wang J; Chen Y
Life Sci; 2017 Dec; 190():46-51. PubMed ID: 28962866
[TBL] [Abstract][Full Text] [Related]
6. Myristicin-induced neurotoxicity in human neuroblastoma SK-N-SH cells.
Lee BK; Kim JH; Jung JW; Choi JW; Han ES; Lee SH; Ko KH; Ryu JH
Toxicol Lett; 2005 May; 157(1):49-56. PubMed ID: 15795093
[TBL] [Abstract][Full Text] [Related]
7. Metabolic Activation of Myristicin and Its Role in Cellular Toxicity.
Zhu X; Wang YK; Yang XN; Xiao XR; Zhang T; Yang XW; Qin HB; Li F
J Agric Food Chem; 2019 Apr; 67(15):4328-4336. PubMed ID: 30912427
[TBL] [Abstract][Full Text] [Related]
8. In vitro inhibitory effect of piperlonguminine isolated from Piper longum on human cytochrome P450 1A2.
Song M; Hwang JY; Lee MY; Jee JG; Lee YM; Bae JS; Kim JA; Lee SH; Lee S
Arch Pharm Res; 2014 Aug; 37(8):1063-8. PubMed ID: 24194261
[TBL] [Abstract][Full Text] [Related]
9. Metabolism of myristicin by Depressaria pastinacella CYP6AB3v2 and inhibition by its metabolite.
Mao W; Zangerl AR; Berenbaum MR; Schuler MA
Insect Biochem Mol Biol; 2008 Jun; 38(6):645-51. PubMed ID: 18510976
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo metabolism of myristicin in the rat.
Lee HS; Jeong TC; Kim JH
J Chromatogr B Biomed Sci Appl; 1998 Feb; 705(2):367-72. PubMed ID: 9521577
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxicity of safrole in HepaRG cells: studies on the role of CYP1A2-mediated ortho-quinone metabolic activation.
Hu L; Wu F; He J; Zhong L; Song Y; Shao H
Xenobiotica; 2019 Dec; 49(12):1504-1515. PubMed ID: 30865484
[TBL] [Abstract][Full Text] [Related]
12. Induction of rat hepatic cytochrome P450 enzymes by myristicin.
Jeong HG; Yun CH
Biochem Biophys Res Commun; 1995 Dec; 217(3):966-71. PubMed ID: 8554622
[TBL] [Abstract][Full Text] [Related]
13. Anti-inflammatory effect of myristicin on RAW 264.7 macrophages stimulated with polyinosinic-polycytidylic acid.
Lee JY; Park W
Molecules; 2011; 16(8):7132-42. PubMed ID: 21991618
[TBL] [Abstract][Full Text] [Related]
14. Toxicological evaluation of myristicin.
Hallström H; Thuvander A
Nat Toxins; 1997; 5(5):186-92. PubMed ID: 9496377
[TBL] [Abstract][Full Text] [Related]
15. The inhibition of CYP1A2, CYP2C9, and CYP2D6 by pterostilbene in human liver microsomes.
Albassam AA; Ahad A; Alsultan A; Yusufoglu HS; Foudah AI; Al-Jenoobi FI
Pharmazie; 2021 Apr; 76(4):155-158. PubMed ID: 33849700
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the anxiolytic properties of myristicin, a component of nutmeg, in the male Sprague-Dawley rat.
Leiter E; Hitchcock G; Godwin S; Johnson M; Sedgwick W; Jones W; McCall S; Ceremuga TE
AANA J; 2011 Apr; 79(2):109-14. PubMed ID: 21560973
[TBL] [Abstract][Full Text] [Related]
17. Use of Human Plasma Samples to Identify Circulating Drug Metabolites that Inhibit Cytochrome P450 Enzymes.
Eng H; Obach RS
Drug Metab Dispos; 2016 Aug; 44(8):1217-28. PubMed ID: 27271369
[TBL] [Abstract][Full Text] [Related]
18. Physiologically based kinetic modeling of the bioactivation of myristicin.
Al-Malahmeh AJ; Al-Ajlouni A; Wesseling S; Soffers AE; Al-Subeihi A; Kiwamoto R; Vervoort J; Rietjens IM
Arch Toxicol; 2017 Feb; 91(2):713-734. PubMed ID: 27334372
[TBL] [Abstract][Full Text] [Related]
19. Preferential overexpression of a class MU glutathione S-transferase subunit in mouse liver by myristicin.
Ahmad H; Tijerina MT; Tobola AS
Biochem Biophys Res Commun; 1997 Jul; 236(3):825-8. PubMed ID: 9245741
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of benzo[a]pyrene-induced tumorigenesis by myristicin, a volatile aroma constituent of parsley leaf oil.
Zheng GQ; Kenney PM; Zhang J; Lam LK
Carcinogenesis; 1992 Oct; 13(10):1921-3. PubMed ID: 1423855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]